AnaSpec has introduced the industry’s most comprehensive collection of anti-MMP zebrafish (Z-Fish(TM)) specific antibodies. AnaSpec’s existing portfolio of MMP research products includes SensoLyte(R) MMP assay kits, GO(TM) (catalog) MMP peptides, and MMP recombinant proteins products. The new MMP products include a wide selection of Z-Fish(TM) as well as human-specific MMP antibodies. Matrix metalloproteinases (MMPs) are members of a family of secreted or membrane-associated zinc endopeptidases involved in both normal and diseased tissue remodeling.

For the full story, Click Here

PDL BioPharma, Inc. has announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL’s Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules. Teplizumab is currently being studied by Lilly and its partner MacroGenics for the treatment of individuals with newly-diagnosed type 1 diabetes mellitus. No other details of the licensing agreement were made available.

For the full story, Click Here

A study published in the Archives of Internal Medicine divided a group of 106 overweight and obese people into two groups: About half spent a year following a diet low in fat – say goodbye to steak and pastries – and high in carbohydrates. The other half went for a year on a low-carb, high-fat diet – have a burger, but skip the bun. In both groups, people lost an average of 30 pounds each.

For the full story, click here

The Adrima Corporation has announced that they will be offering a new antioxidant supplement that utilizes Effective Microorganisms™. This is an innovative green technology which is beneficial for humans, animals, and plants. With healthcare costs at an all time high, the company has stated that their product is an effective way to take preventative action and help avoid unnecessary and costly medical problems in the future.

A study from University of Toronto claims that adults who underwent physical abuse as children have about 56 per cent more chances of suffering from osteoarthritis as opposed to those who have not been abused. Osteoarthritis is said to occasionally be an incapacitating severe condition that affects millions of adults. The experts examined the affiliation between self-reported childhood physical abuse and detection of osteoarthritis (OA).